Correlation Between Adicet Bio and Heartbeam
Can any of the company-specific risk be diversified away by investing in both Adicet Bio and Heartbeam at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adicet Bio and Heartbeam into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adicet Bio and Heartbeam, you can compare the effects of market volatilities on Adicet Bio and Heartbeam and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adicet Bio with a short position of Heartbeam. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adicet Bio and Heartbeam.
Diversification Opportunities for Adicet Bio and Heartbeam
-0.23 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Adicet and Heartbeam is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Adicet Bio and Heartbeam in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam and Adicet Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adicet Bio are associated (or correlated) with Heartbeam. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam has no effect on the direction of Adicet Bio i.e., Adicet Bio and Heartbeam go up and down completely randomly.
Pair Corralation between Adicet Bio and Heartbeam
Given the investment horizon of 90 days Adicet Bio is expected to under-perform the Heartbeam. But the stock apears to be less risky and, when comparing its historical volatility, Adicet Bio is 3.61 times less risky than Heartbeam. The stock trades about -0.16 of its potential returns per unit of risk. The Heartbeam is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 176.00 in Heartbeam on October 7, 2025 and sell it today you would earn a total of 98.00 from holding Heartbeam or generate 55.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adicet Bio vs. Heartbeam
Performance |
| Timeline |
| Adicet Bio |
| Heartbeam |
Adicet Bio and Heartbeam Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adicet Bio and Heartbeam
The main advantage of trading using opposite Adicet Bio and Heartbeam positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adicet Bio position performs unexpectedly, Heartbeam can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam will offset losses from the drop in Heartbeam's long position.| Adicet Bio vs. Lite Strategy | Adicet Bio vs. IO Biotech | Adicet Bio vs. Tscan Therapeutics | Adicet Bio vs. Adagene |
| Heartbeam vs. OneMedNet Corp | Heartbeam vs. OS Therapies Incorporated | Heartbeam vs. Werewolf Therapeutics | Heartbeam vs. Spruce Biosciences Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |